Chondrosulf Chondroïtine Sulfate Sodique 400mg,84

Categories: Non prescription, Pain
Problems: Hip pain, Knee pain

$53,13

In stock
Other products from this and related problems

Chondrosulf (Chondroïtine Sulfate Sodique) – 400 mg, 84 Capsules

Slow‑Acting Symptomatic Relief for Osteoarthritis of the Knee & Hip

A pharmaceutical-grade chondroitin sulfate formulation from IBSA, intended to reduce joint pain and improve mobility in osteoarthritis—backed by EU regulatory approval.


🌿 What Is It?

  • Each capsule delivers 400 mg of sodium chondroitin sulfate, a natural component of cartilage that helps cushion joints 

  • Swiss-quality preparation developed for slow-release benefits, typically requiring 2 months or more to show effects, which may persist even after discontinuation 


Key Benefits

  • Eases joint pain and stiffness in knee and hip osteoarthritis, improving functional comfort

  • May slow cartilage degradation and exert mild anti-inflammatory effects—though scientific opinions differ on its overall effectiveness 

  • Well tolerated; most users report mild GI symptoms only, and long-term use up to six years is considered safe 


🕒 How to Use

  • Adults (15+ years): 3 capsules daily (total 1200 mg/day) with meals—typically 1 capsule three times a day .

  • Treatment duration: Minimum of 2 months to assess benefit; can continue longer for chronic joint support .


⚠️ Precautions & Interactions

  • Avoid during pregnancy and breastfeeding without medical advice .

  • Watch for mild GI side effects, such as bloating, diarrhea, or nausea .

  • Rare risk of bleeding if combined with anticoagulants (e.g., warfarin)—consult your doctor if on blood thinners .

  • Use caution if you have asthma or pre-existing prostate cancer risk .

  • Label variability means product quality can differ; pharmaceutical-grade (like Chondrosulf) offers consistent dosing 


📚 Clinical Evidence

  • A 2018 review of 26 studies found modest improvements in pain and joint function compared to placebo 

  • The European League Against Rheumatism recognizes chondroitin as a symptomatic slow-acting drug (SYSADOA) in Europe, though major guidelines remain cautious about its use 

  • Cochrane reviews note mixed results—while some trials show benefit, others do not, and discrepancy may stem from study quality .

buy Chondrosulf Chondroïtine Sulfate Sodique